Elizabeth Katherine Lee, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ovarian Neoplasms | 7 | 2023 | 4838 | 1.110 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2020 | 450 | 0.710 |
Why?
|
Maytansine | 1 | 2019 | 80 | 0.650 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2022 | 11524 | 0.490 |
Why?
|
Doxorubicin | 1 | 2020 | 2234 | 0.470 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 523 | 0.460 |
Why?
|
Immunoconjugates | 1 | 2019 | 901 | 0.400 |
Why?
|
Uterine Neoplasms | 1 | 2020 | 1513 | 0.390 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13695 | 0.320 |
Why?
|
Endometrial Neoplasms | 3 | 2022 | 1353 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5172 | 0.190 |
Why?
|
Deoxycytidine | 2 | 2021 | 826 | 0.180 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2019 | 10 | 0.180 |
Why?
|
Folate Receptor 1 | 1 | 2019 | 36 | 0.170 |
Why?
|
DNA Polymerase II | 1 | 2019 | 107 | 0.160 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2020 | 198 | 0.160 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 434 | 0.150 |
Why?
|
Phenylurea Compounds | 1 | 2020 | 528 | 0.150 |
Why?
|
Thromboplastin | 1 | 2019 | 291 | 0.150 |
Why?
|
CA-125 Antigen | 1 | 2019 | 286 | 0.140 |
Why?
|
Camptothecin | 1 | 2019 | 576 | 0.130 |
Why?
|
Quinolines | 1 | 2020 | 732 | 0.130 |
Why?
|
Infusions, Intravenous | 1 | 2020 | 2274 | 0.130 |
Why?
|
Drug Synergism | 1 | 2019 | 1792 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1182 | 0.120 |
Why?
|
DNA Replication | 1 | 2021 | 1399 | 0.120 |
Why?
|
Drug Design | 1 | 2019 | 1076 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1275 | 0.110 |
Why?
|
Hospitalists | 1 | 2017 | 305 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2948 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1602 | 0.110 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4933 | 0.100 |
Why?
|
Membrane Proteins | 2 | 2019 | 7880 | 0.100 |
Why?
|
Female | 14 | 2023 | 380194 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2017 | 591 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2019 | 1988 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1049 | 0.090 |
Why?
|
Fatigue | 1 | 2017 | 1531 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6895 | 0.090 |
Why?
|
Toll-Like Receptor 4 | 1 | 2013 | 565 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1333 | 0.090 |
Why?
|
Isoxazoles | 2 | 2021 | 216 | 0.090 |
Why?
|
Survival Rate | 2 | 2020 | 12788 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2727 | 0.080 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2013 | 341 | 0.080 |
Why?
|
Microcirculation | 1 | 2013 | 1286 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10943 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3597 | 0.080 |
Why?
|
Pancreatitis | 1 | 2014 | 1092 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2020 | 11366 | 0.070 |
Why?
|
Humans | 15 | 2023 | 744343 | 0.070 |
Why?
|
Ligands | 2 | 2022 | 3282 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5535 | 0.060 |
Why?
|
Pyrazines | 2 | 2021 | 1230 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.060 |
Why?
|
Disease Progression | 1 | 2020 | 13284 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3843 | 0.060 |
Why?
|
Communication | 1 | 2017 | 3749 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 7913 | 0.060 |
Why?
|
Signal Transduction | 2 | 2019 | 23403 | 0.060 |
Why?
|
Ribose | 1 | 2022 | 68 | 0.050 |
Why?
|
Diphosphates | 1 | 2022 | 88 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3036 | 0.050 |
Why?
|
Mutation | 3 | 2021 | 29786 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2019 | 6364 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5256 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 97 | 0.050 |
Why?
|
Phthalazines | 1 | 2022 | 363 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3114 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 426 | 0.040 |
Why?
|
Platinum | 1 | 2020 | 233 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 170 | 0.040 |
Why?
|
Aged | 5 | 2022 | 163280 | 0.040 |
Why?
|
Middle Aged | 6 | 2020 | 213383 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 63114 | 0.040 |
Why?
|
Carboplatin | 1 | 2019 | 801 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1265 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1086 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20822 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2187 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9239 | 0.030 |
Why?
|
Hospital Administration | 1 | 2017 | 353 | 0.030 |
Why?
|
Nitrites | 1 | 2013 | 160 | 0.030 |
Why?
|
Pennsylvania | 1 | 2014 | 613 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2022 | 2416 | 0.030 |
Why?
|
Nitrates | 1 | 2013 | 265 | 0.030 |
Why?
|
Paclitaxel | 1 | 2019 | 1708 | 0.020 |
Why?
|
Infant Formula | 1 | 2013 | 199 | 0.020 |
Why?
|
Sulfones | 1 | 2013 | 437 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2013 | 689 | 0.020 |
Why?
|
Purines | 1 | 2013 | 594 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 21683 | 0.020 |
Why?
|
Milk, Human | 1 | 2013 | 490 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6756 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2013 | 2726 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1970 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2531 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2518 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9274 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2013 | 2132 | 0.010 |
Why?
|
Population Surveillance | 1 | 2014 | 2616 | 0.010 |
Why?
|
Piperazines | 1 | 2013 | 2488 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 85781 | 0.010 |
Why?
|
Young Adult | 2 | 2020 | 56430 | 0.010 |
Why?
|
Adult | 3 | 2020 | 214055 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14557 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
Risk Factors | 1 | 2014 | 72290 | 0.000 |
Why?
|
Mice | 1 | 2013 | 81183 | 0.000 |
Why?
|
Animals | 1 | 2013 | 168757 | 0.000 |
Why?
|
Male | 1 | 2014 | 350118 | 0.000 |
Why?
|